Bristol-Myers Squibb Firm (NYSE:BMY) Citi’s 2024 International Healthcare Convention December 3, 2024 8:00 AM ET
Firm Members
Christopher Boerner – CEO and Board Chair
David Elkins – EVP and CFO
Convention Name Members
Geoff Meacham – Citi
Mary Kate Davis – Citi
Geoff Meacham
Welcome to the primary session of the First Annual International Healthcare Convention at Citi. We’re thrilled to be right here and we’re thrilled to have with us. My title is Geoff Meacham. I am the Senior Biopharma Analyst and we’ve Mary Kate Davis from my staff on stage too. We’re thrilled to kick it off with Bristol at this time.
So we’ve CEO Chris Boerner, and we’ve CFO David Elkins. Welcome, guys.
Christopher Boerner
Thanks. It is nice to be right here.
David Elkins
Good to be right here.
Geoff Meacham
So we will simply do a fireplace right here for about half an hour, after which, you guys, there is a QR code you probably have questions. And I’ve the viewers response factor right here. I have already got a pair loaded, so that you’re welcome so as to add that. We are able to try this on the very finish. So, I do not know, Chris, do you wish to begin off with something sort of excessive stage, how we should always take into consideration 2025 from a occasion, or like a method perspective?
Query-and-Reply Session
A – Christopher Boerner
Positive. Effectively, look, let’s begin with 2024. 2024, first yr as CEO, and I’d say, we’re pleased with the place we’re. Our focus as an organization is on delivering within the short-term, however actually importantly, setting a basis for long-term sustainable progress. And we imagine we’ve the substrate to ship high tier progress throughout the sector by the top of the last decade. And so it is all been about this yr specializing in execution, execution on the near-term drivers of our progress portfolio, however persevering with to get that pipeline working